Leukemia, B-cell
Oncology·MeSH: Leukemia, B-Cell
Prevalence
30.4 / 100K
Incidence
7.5 / 100K/yr
1 drug in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 1(1)
Frequently asked questions
How many drugs are in development for Leukemia, B-cell?
BioSniper tracks 1 drug in development for Leukemia, B-cell across 1 company.
How many clinical trials target Leukemia, B-cell?
There are 3 clinical trials targeting Leukemia, B-cell tracked by BioSniper.
What is the prevalence of Leukemia, B-cell?
The estimated prevalence of Leukemia, B-cell is approximately 30.4 per 100,000 population.
Deep-dive into Leukemia, B-cell
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis